Bayer CEO: 2025 Will Be 'Most Difficult' Year In Turnaround Plan, Expects Improved Performance From 2026 Onwards
Bayer reported Q4 adjusted EPS of $0.28, missing estimates, but sales beat forecasts. The company sees 2025 as a tough year, with growth expected from 2026.
Bayer sees FY25 sales roughly at prior-year level
Expects EBITDA before special items and core EPS to decline. CEO Bill Anderson said, “We all look forward to being able to pay out a larger ...
Bayer reports Q4 core EPS EUR 1.05 vs. EUR 1.85 last year
Group sales came in at EUR 11.7B vs. EUR 11.9B last year. EBITDA before special items was EUR 2.3B vs. EUR 3B last year. Group EBIT came in at ...